First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis

Status:
Completed

Trial end date:
2019-10-04

Target enrollment:

Participant gender:

First in Human single ascending dose followed by multiple ascending doses in healthy volunteers.

Phase 1

Blade Therapeutics